Johnson & Johnson offers safer payouts and stronger growth. Discover why JNJ stock is the better dividend option compared to ...

UBS lowered the firm’s price target on Pfizer (PFE) to $29 from $31 and keeps a Neutral rating on the shares as part of a broader note on the ...

In a report released yesterday, Srikripa Devarakonda from Truist Financial maintained a Buy rating on Pfizer (PFE – Research Report), with a ...

Pfizer (PFE) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock. Shares ...

Check the time stamp on this data. Updated AI-Generated Signals for Pfizer Inc. (PFE) available here: PFE.

Investors continued to sell off shares in Sangamo Therapeutics Inc. (NASDAQ:SGMO) before market open on Tuesday following ...

The article " Pfizer: 4 Reasons to Buy This Stock " first appeared on MarketBeat.

Sales and earnings have plunged since the pandemic ended, sending Pfizer stock down over 50% off its former high. As terrible ...

The equity is pulling back slightly today, though it remains well above its Nov. 15 dip to $24.48 -- its lowest mark since ...

Today, Benzinga 's options scanner spotted 9 uncommon options trades for Pfizer. This isn't normal. The overall sentiment of ...

Highlights,Pfizer increases dividend for the upcoming year to $0.43.,Dividend payout ratio expected to decrease but could ...

Pfizer's oncology promises are several years from being actualized. Read why investors shouldn't assume that a sustained ...